Search Results - michael+mullins

2 Results Sort By:
Implantable Multilayer 3D Scaffold Consisting of Highly Aligned Electrospun Fibers for Neuronal Regeneration Applications
C10716: Implantable Multilayer 3D Scaffold for Neuronal Regeneration ApplicationsValue Proposition:The multilayer 3D conduit is a superior candidate for nerve repair and clinical regeneration applications.• The novel wall structure made of double-sided fibers increases the opportunities for cell migration so that more cells populate the regenerating...
Published: 3/13/2025   |   Inventor(s): Jared Cregg, Han Wang, Michael Mullins, Martin Oudega, Ryan Gilbert, Andres Hurtado
Keywords(s): CNS and Neurological Disorders, Disease Indication, Drug Delivery Vehicle, Hydrogel, Implanted Device, Implants, Spinal Cord Injury, Therapeutic Devices, Therapeutic Matter, Therapeutics, Tissue Engineering/Regenerative Devices
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Neurology > Spinal Cord Injury, Clinical and Disease Specializations > Traumatic Injury, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Clinical and Disease Specializations > Neurology, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Dendrimers & Polymers, Technology Classifications > Medical Devices > Regenerative Medicine
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 3/13/2025   |   Inventor(s): Li Lin
Keywords(s): Biologics, Cancers, Chemotherapy, Disease Indication, Nucleic Acid, Single, Skin Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Dermatology, Clinical and Disease Specializations > Oncology > Skin Cancer, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum